No abstract available.
Biopsy, Fine-Needle* ; Hamartoma*

PURPOSE: The aim of this study is to explore levels of suicidal ideation and identify subgroups of high suicidal risk among the depressed elderly in Korea. METHODS: A descriptive cross-sectional design was adopted on secondary data from the 6th (1st year) Korean national health and nutrition examination survey (KNHANES). A total of 239 depressed elders aged 60 or over who participated in the KNHANES. The prevalence of suicidal ideation and its related factors, including sociodemographic, physical, psychological characteristics and quality of life (EQ-5D index) were examined. Descriptive statistics and a decision tree analysis were performed using the SPSS/WIN 23.0 and SPSS Modeler 14.2 programs. RESULTS: Of the depressed elderly, 28.9% had suicidal ideation. Three groups with high suicidal ideation were identified. Predictive factors included perceived stress level, household income level, quality of life and restriction of activity. In the highest risk group were those depressed elderly with moderate and low levels of stress, less than .71 of EQ-5D index and restriction of activity, and 80.0% of these participants had suicidal ideation. The accuracy of the model was 80.8%, its sensitivity 85.9%, and its specificity 68.1%. CONCLUSION: Multi-dimensional intervention should be designed to decrease suicide among the depressed elderly, particularly focusing on subgroups with high risk factors. This research is expected to contribute itself to the policy design and solution building in the future as it suggests policy implications in preventing the suicide of the depressed elderly.
Aged ; Decision Trees ; Depression ; Family Characteristics ; Humans ; Korea ; Nutrition Surveys ; Prevalence ; Quality of Life ; Risk Factors ; Sensitivity and Specificity ; Suicidal Ideation ; Suicide

Purpose: Vaccine hesitancy is among the top ten threats to global health, and access to precise data on adverse events following immunization (AEFIs) is imperative to alleviate public concerns surrounding vaccines. This study aimed to present the overall trends of AEFIs reported in South Korea. Materials and Methods: We evaluated the trends of AEFIs using the Korea Institute of Drug Safety & Risk Management-Korea Adverse Event Reporting System database between January 2005 and December 2017. AEFIs were classified into five categories to evaluate associations between vaccines and AEFIs through a case-non-case study: neurologic reactions, general systemic reactions, local reactions, allergic reactions, and others. Results: Among 54378 reported adverse events (AEs) associated with all vaccines approved in South Korea, more than half (56.7%) occurred following influenza vaccination, followed by the pneumococcal (11.6%) and Bacillus Calmette-Guérin (BCG) vaccines (5.0%). After immunization with most vaccines, general systemic reactions were most common, followed by local and neurologic reactions. Adjusted reporting odds ratios were calculated for all neurologic, general, local, and allergic reactions: of all vaccines, rotavirus [neurologic 2.43, 95% confidence interval (CI), 2.25–2.62], BCG (general; 2.20, 95% CI, 1.91–2.53), BCG (local; 3.15, 95% CI, 2.69–3.68), and Japanese encephalitis (allergic 2.38, 95% CI, 1.98–2.87) vaccines showed the highest values. Conclusion The majority of reported AEFIs were non-serious and mostly general systemic reactions. Sufficient knowledge on the AEFIs would secure public confidence on the safety of vaccines, thereby reducing public health burden from vaccine-preventable diseases.

Here we present a rare case of an adolescent with hypertension, concurrently diagnosed with fibromuscular dysplasia of the renal artery and Graves’ disease. Although fibromuscular dysplasia and Graves’ disease have distinct pathogenic mechanisms, it is possible to infer the potential correlation between the two from the perspective of vascular involvement. It is believed that transforming growth factor-β, as the shared element of both diseases, may contribute to their development and progression. The overactivation of the sympathetic nervous system in Graves’ disease may induce hyperplasia of vascular smooth muscle cells, similar to that observed in fibromuscular dysplasia. In Graves’ disease, the excessive synthesis and secretion of angiotensin II due to the overactivation of the renin-angiotensin system, along with the up-regulation of angiotensin II receptors, may also induce pathological changes in the vasculature throughout the body. In this regard, exploring the correlation between fibromuscular dysplasia and Graves’ disease is of significant clinical importance.

Purpose: This study investigated the impacts of disease perception, stigma, distress, and physical symptom experience on the quality of life of colorectal cancer patients receiving chemotherapy. Methods: A descriptive study was conducted on 127 colorectal cancer patients receiving chemotherapy from June 2023 to November 2023. The collected data were analyzed using the t-test, analysis of variance, Pearson correlation coefficients, and hierarchical regression analysis in SPSS 26. Results: The participants' occupation (β=.14, p=.002), religion (β=.11, p=.018), disease perception (β=-.24, p<.001), stigma (β=-.12, p=.028), distress (β=-.44, p<.001), and physical symptom experience (β=-.16, p=.004) were significant factors influencing the quality of life of colorectal cancer patients receiving chemotherapy, and the explanatory power of the model was found to be 78%. Conclusion The results of this study suggest the need to prepare various intervention strategies to comprehensively manage disease perception, stigma, distress, and physical symptom experiences in colorectal cancer patients receiving chemotherapy, thereby improving their quality of life.

Purpose: This study investigated the impacts of disease perception, stigma, distress, and physical symptom experience on the quality of life of colorectal cancer patients receiving chemotherapy. Methods: A descriptive study was conducted on 127 colorectal cancer patients receiving chemotherapy from June 2023 to November 2023. The collected data were analyzed using the t-test, analysis of variance, Pearson correlation coefficients, and hierarchical regression analysis in SPSS 26. Results: The participants' occupation (β=.14, p=.002), religion (β=.11, p=.018), disease perception (β=-.24, p<.001), stigma (β=-.12, p=.028), distress (β=-.44, p<.001), and physical symptom experience (β=-.16, p=.004) were significant factors influencing the quality of life of colorectal cancer patients receiving chemotherapy, and the explanatory power of the model was found to be 78%. Conclusion The results of this study suggest the need to prepare various intervention strategies to comprehensively manage disease perception, stigma, distress, and physical symptom experiences in colorectal cancer patients receiving chemotherapy, thereby improving their quality of life.

Purpose: This study investigated the impacts of disease perception, stigma, distress, and physical symptom experience on the quality of life of colorectal cancer patients receiving chemotherapy. Methods: A descriptive study was conducted on 127 colorectal cancer patients receiving chemotherapy from June 2023 to November 2023. The collected data were analyzed using the t-test, analysis of variance, Pearson correlation coefficients, and hierarchical regression analysis in SPSS 26. Results: The participants' occupation (β=.14, p=.002), religion (β=.11, p=.018), disease perception (β=-.24, p<.001), stigma (β=-.12, p=.028), distress (β=-.44, p<.001), and physical symptom experience (β=-.16, p=.004) were significant factors influencing the quality of life of colorectal cancer patients receiving chemotherapy, and the explanatory power of the model was found to be 78%. Conclusion The results of this study suggest the need to prepare various intervention strategies to comprehensively manage disease perception, stigma, distress, and physical symptom experiences in colorectal cancer patients receiving chemotherapy, thereby improving their quality of life.

Serotonin syndrome is an unexpected fatal adverse event related to serotonergic medication. This case report is the first report describing the possible treatment effect of famotidine on serotonin syndrome. Furthermore, this is the first case report of serotonin syndrome induced by meperidine alone in a patient with no previous history suggesting a susceptibility to serotonin syndrome. A 70-year-old male with no recent history of serotonergic drug use presented with severe serotonin syndrome following ureteroscopy, possibly due to postoperative meperidine administration. The patient's symptoms included hypertension, tachycardia, tachypnea, hyperthermia, myoclonus, diaphoresis, retching, nausea, agitation, and semicoma mentality with no pupillary light reflex. Symptoms began to subside immediately after the administration of intravenous famotidine for prevention of aspiration pneumonia, with mental and neurological symptoms showing improvement initially, followed by autonomic symptoms. This case report suggests that the histamine type 2 receptor antagonist famotidine may be an effective emergency treatment for serotonin syndrome.
Aged ; Dihydroergotamine ; Emergency Treatment ; Famotidine ; Fever ; Histamine ; Histamine H2 Antagonists ; Humans ; Hypertension ; Male ; Meperidine ; Myoclonus ; Nausea ; Pneumonia, Aspiration ; Reflex ; Serotonin Syndrome* ; Serotonin* ; Tachycardia ; Tachypnea ; Ureteroscopy

Serotonin syndrome is an unexpected fatal adverse event related to serotonergic medication. This case report is the first report describing the possible treatment effect of famotidine on serotonin syndrome. Furthermore, this is the first case report of serotonin syndrome induced by meperidine alone in a patient with no previous history suggesting a susceptibility to serotonin syndrome. A 70-year-old male with no recent history of serotonergic drug use presented with severe serotonin syndrome following ureteroscopy, possibly due to postoperative meperidine administration. The patient's symptoms included hypertension, tachycardia, tachypnea, hyperthermia, myoclonus, diaphoresis, retching, nausea, agitation, and semicoma mentality with no pupillary light reflex. Symptoms began to subside immediately after the administration of intravenous famotidine for prevention of aspiration pneumonia, with mental and neurological symptoms showing improvement initially, followed by autonomic symptoms. This case report suggests that the histamine type 2 receptor antagonist famotidine may be an effective emergency treatment for serotonin syndrome.
Aged ; Dihydroergotamine ; Emergency Treatment ; Famotidine ; Fever ; Histamine ; Histamine H2 Antagonists ; Humans ; Hypertension ; Male ; Meperidine ; Myoclonus ; Nausea ; Pneumonia, Aspiration ; Reflex ; Serotonin Syndrome* ; Serotonin* ; Tachycardia ; Tachypnea ; Ureteroscopy

This review explores the current status and future potential of digital therapeutics (DTx), emphasizing their role in clinical practice. It focuses on clarifying their classification, clinical applications, regulatory challenges, and prospective developments in the field.Current Concepts: Digital therapeutics are evidence-based interventions delivered via software to prevent, manage, and treat medical conditions. Unlike traditional pharmacotherapy, DTx products can be updated and modified, offering greater flexibility in treatment delivery. They are categorized into behavior-modification, physiological-modulation, and disease-management types, and are primarily applied to chronic conditions and neuropsychological disorders. Global regulatory frameworks are rapidly evolving to accommodate this burgeoning field.Discussion and Conclusion: Digital therapeutics offer significant advantages over traditional pharmacotherapy, such as lower development costs, personalized treatment options, and improved accessibility. These innovations have the potential to transform healthcare by complementing existing therapies and enabling data-driven, individualized care. However, several key challenges must be addressed for widespread adoption. Patient adherence remains inconsistent, particularly in longterm treatments, which can limit clinical effectiveness. In addition, underdeveloped reimbursement policies create economic uncertainty, and ongoing concerns regarding data security and privacy pose persistent risks. As technology advances, digital therapeutics are poised to enhance clinical outcomes, expand access to care, and transform traditional healthcare models, ultimately driving innovation in modern medicine.